Pfizer logo

Pfizer dividend paidNYSE: PFE

TTMAnnual

Dividend paid (quarterly)

$2.38 B
$0.000.00%

30 September 2024

new highvs 3 years high
+8.92%vs 3 years low
97.60%vs. sector
Performance
Most recent0.0%
1 year+2.9%
3 years+8.9%
5 years+18.8%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend paid (quarterly) performance

Most recent change
PFE0.0%
SYK0.0%
BSX0.0%
AMGN+0.1%
BMY-0.1%
1 year change
PFE+2.9%
SYK+7.0%
BSX0.0%
AMGN+6.1%
BMY+2.1%
3 years change
PFE+8.9%
SYK+28.1%
BSX-100.0%
AMGN+21.1%
BMY+11.6%
5 years change
PFE+18.8%
SYK+56.4%
BSX0.0%
AMGN+39.4%
BMY+81.2%

Dividend paid (quarterly) performance

PFESYKBSXAMGNSNYBMYVRTX
Most recent0.0%0.0%0.0%+0.1%--0.1%-
1 year+2.9%+7.0%0.0%+6.1%-+2.1%-
3 years+8.9%+28.1%-100.0%+21.1%-+11.6%-
5 years+18.8%+56.4%0.0%+39.4%-+81.2%-
FAQ

What is Pfizer dividend paid (quarterly)?

Pfizer dividend paid (quarterly) is $2.38 B

What is Pfizer dividend paid (quarterly) compared to its all-time maximum value?

Pfizer dividend paid (quarterly) is 100% of its all-time maximum value

What is Pfizer dividend paid (quarterly) compared to other companies from its sector (Healthcare)?

Pfizer dividend paid (quarterly) is higher than 97.6% of the companies in the same sector (Healthcare)

How has Pfizer dividend paid (quarterly) changed over the year?

Over the past year, Pfizer dividend paid (quarterly) has increased by 2.9%. During the same period, Stryker has increased by 7.0%, Boston Scientific has not changed, Amgen has grown by 6.1%, Bristol-Myers Squibb has risen by 2.1%

How has Pfizer dividend paid (quarterly) changed over the 3 years?

During the last 3 years, Pfizer dividend paid (quarterly) has increased by 8.9%. Over the same period, Stryker has increased by 28.1%, Boston Scientific has decreased by 100.0%, Amgen has grown by 21.1%, Bristol-Myers Squibb has risen by 11.6%

How has Pfizer dividend paid (quarterly) changed over the 5 years?

For the past 5 years, Pfizer dividend paid (quarterly) has increased by 18.8%. In the same period, Stryker has increased by 56.4%, Boston Scientific has not changed, Amgen has grown by 39.4%, Bristol-Myers Squibb has risen by 81.2%